Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients With MIBC (RAD-SG).

NCT05833867 is registered in ClinicalTrials.gov with Shilpa Gupta, MD as lead sponsor.

NCT NCT05833867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05833867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Bladder Preservation in Patients With MIBC (RAD-SG).
Lead sponsor
Shilpa Gupta, MD
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2024
Completion date
October 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized muscle invasive bladder urothelial carcinoma, muscle-invasive bladder carcinoma